Plus   Neg

Pfizer Boosts FY19 Adj. EPS Outlook - Quick Facts

While reporting financial results for the first quarter, Pfizer Inc. (PFE) on Tuesday raised its full-year 2019 guidance for adjusted earnings, while reaffirming its full-year revenue outlook.

For fiscal 2019, the company increased its outlook for adjusted earnings by one cent to a range of $2.83 to $2.93 per share.

However, the company continues to project revenues between $52.0 billion and $54.0 billion

On average, analysts polled by Thomson Reuters expect the company to report earnings of $2.89 per share on revenues of $53.25 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Beyond Meat Inc. (BYND), the meatless burger and sausage maker, announced the appointment of Sanjay Shah as Chief Operating Officer. Shah will assume the responsibility for Beyond Meat's global operations and production, effective September 18. "It is with great enthusiasm that I welcome Sanjay... A federal court has sentenced the former President of drug compounding company Pharmakon Pharmaceuticals Inc. to prison for defrauding the U.S. Food and Drug Administration and distributing adulterated drugs, the U.S. Department of Justice said. District Judge James Sweeney sentenced Paul Elmer, 68, the former president and owner of Pharmakon Pharmaceuticals Inc. to 33 months in prison. Amazon on Thursday unveiled its ambitious plans to combat climate change, with the announcement coming just a day before its employees plan to walk out of the Seattle headquarters to protest the e-commerce giant's climate policies. The company said it has co-founded the Climate Pledge, a plan to make companies carbon neutral by 2040 and reach the goal of the Paris Accord ten years early.
Follow RTT